Eledon Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Eledon Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Eledon Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 41.2M shares, a 74.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 41.2M +17.6M +74.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 38.5M +15.5M +67.1% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 24.8M +11M +80.1% Mar 31, 2024 10-Q/A 2024-08-19
Q4 2023 24.2M +10.4M +75.8% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 23.5M +9.79M +71.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 23M +9.29M +67.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 13.8M +20K +0.15% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 13.8M -530K -3.71% Dec 31, 2022 10-K/A 2024-08-19
Q3 2022 13.8M -550K -3.84% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 13.8M -550K -3.84% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 13.8M -550K -3.84% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 14.3M -854K -5.63% Dec 31, 2021 10-K 2023-03-30
Q3 2021 14.3M +13M +1022% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 14.3M -5.07M -26.2% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 14.3M -1.76M -11% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 15.2M +14.4M +2004% Dec 31, 2020 10-K 2022-03-24
Q3 2020 1.27M -11.7M -90.2% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 19.4M +6.4M +49.4% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 16.1M +6.62M +70.1% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 720K -8.7M -92.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 13M +3.55M +37.7% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 13M +3.57M +37.9% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 9.45M +40.3K +0.43% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 9.42M +2.31M +32.5% Dec 31, 2018 10-K 2020-03-17
Q3 2018 9.42M +2.48M +35.7% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 9.41M +2.46M +35.5% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 9.41M -13.2M -58.5% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 7.11M +6.72M +1703% Dec 31, 2017 10-K 2019-03-28
Q3 2017 6.94M -15.7M -69.3% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 6.94M -15.7M -69.3% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 22.6M +6.83K +0.03% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 394K -22.2M -98.3% Dec 31, 2016 10-K 2018-04-02
Q3 2016 22.6M +60.1K +0.27% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 22.6M +148K +0.66% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 22.6M +238K +1.06% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 22.6M +215K +0.96% Dec 31, 2015 10-K 2017-03-03
Q3 2015 22.6M +740K +3.39% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 22.5M Jun 30, 2015 10-Q 2015-08-12
Q1 2015 22.4M Mar 31, 2015 10-Q 2015-05-12
Q4 2014 22.4M +21.9M +4437% Dec 31, 2014 10-K 2016-03-10
Q3 2014 21.8M Sep 30, 2014 10-Q 2014-11-13
Q4 2013 493K Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.